Recombinant human adenovirus type 5
重组人5型腺病毒
Report date: 2026/04/29 20:02:18
Base Information
Drug NameRecombinant human adenovirus type 5
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[8]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2006/04/21
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Sunway Bio Co LtdPolaris Group Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesFudan UniversitySun Yat-Sen UniversityWest China Hospital Of Sichuan University +[4]
Inactive CompaniesN/A
Active Indications +[7]
Inactive Indications
Other Information
ATC Code
Related LinksN/A